![Brian McNulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 24 M $ op 31-07-2026
Brian McNulty currently works as a Director at Abtech Precision.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-07-2026 | 19.151.146 ( 59,33% ) | 23 M $ | 31-07-2026 | |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline 1,85% | 21-07-2026 | 779.047 ( 1,85% ) | 617 005 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Abtech Precision
 Abtech Precision Trucks/Construction/Farm MachineryProducer Manufacturing Provides manufacturing sector with machines at a low price | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 1 |
|---|---|
Abtech Precision
Abtech Precision Trucks/Construction/Farm MachineryProducer Manufacturing Provides manufacturing sector with machines at a low price | Producer Manufacturing |
Kies jouw editie
Alle financiële informatie op nationaal niveau
